Patents by Inventor Suhaila White

Suhaila White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7344833
    Abstract: This invention provides novel AP-1 modulatory polypeptides. The invention also provides methods for screening modulators of AP-1 transcription factor activities. The methods comprise first screening test agents for modulators of an AP-1-modulatory polypeptide and then further screening the identified modulating agents for modulators of AP-1 transcription factor activities. The invention further provides methods and pharmaceutical compositions for modulating AP-1 transcription factor activities in a cell and for treating diseases and conditions mediated by abnormal cellular proliferation.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: March 18, 2008
    Assignee: IRM LLC
    Inventors: Sumit Chanda, Suhaila White, John B. Hogenesch, Jeremy S. Caldwell
  • Publication number: 20050048585
    Abstract: This invention provides novel NF-AT-modulatory polypeptides. The invention also provides methods for screening modulators of NF-AT. The methods comprise first screening test agents for modulators of an NF-AT-modulatory polypeptide and then further screening the identified modulating agents for modulators of NF-AT. The invention further provides methods and pharmaceutical compositions for modulating NF-AT bioactivities in a cell and for treating diseases and conditions mediated by abnormal NF-AT activities.
    Type: Application
    Filed: December 10, 2003
    Publication date: March 3, 2005
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Suhaila White, Sumit Chanda, Jeremy Caldwell
  • Publication number: 20040146903
    Abstract: This invention provides novel AP-1 modulatory polypeptides. The invention also provides methods for screening modulators of AP-1 transcription factor activities. The methods comprise first screening test agents for modulators of an AP-1-modulatory polypeptide and then further screening the identified modulating agents for modulators of AP-1 transcription factor activities. The invention further provides methods and pharmaceutical compositions for modulating AP-1 transcription factor activities in a cell and for treating diseases and conditions mediated by abnormal cellular proliferation.
    Type: Application
    Filed: November 5, 2003
    Publication date: July 29, 2004
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Sumit Chanda, Suhaila White, John B. Hogenesch, Jeremy S. Caldwell